Magagnoli C, Manetti R, Fontana M R, Giannelli V, Giuliani M M, Rappuoli R, Pizza M
IRIS, the Chiron Biocine Immunobiological Research Institute Siena, Italy.
Infect Immun. 1996 Dec;64(12):5434-8. doi: 10.1128/iai.64.12.5434-5438.1996.
Heat-labile toxin (LT) is a protein related to cholera toxin, produced by enterotoxigenic Escherichia coli strains, that is organized as an AB5 complex. A number of nontoxic derivatives of LT, useful for new or improved vaccines against diarrheal diseases or as mucosal adjuvants, have been constructed by site-directed mutagenesis. Here we have studied the biochemical properties of the nontoxic mutants LT-K7 (Arg-7-->Lys), LT-D53 (Val-53-->Asp), LT-K63 (Ser-63-->Lys), LT-K97 (Val-97-->Lys), LT-K104 (Tyr-104-->Lys), LT-K114 (Ser-114-->Lys), and LT-K7/K97 (Arg-7-->Lys and Val-97-->Lys). We have found that mutations in the A subunit may have profound effects on the ability to form the AB5 structure and on the stability and trypsin sensitivity of the purified proteins. Unstable mutants, during long-term storage at 4 degrees C, showed a decrease in the amount of the assembled protein in solution and a parallel appearance of soluble monomeric B subunit. This finding suggests that the stability of the B pentamer is influenced by the A subunit which is associated with it. Among the seven nontoxic mutants tested, LT-K63 was found to be efficient in AB5 production, extremely stable during storage, resistant to proteolytic attack, and very immunogenic. In conclusion, LT-K63 is a good candidate for the development of antidiarrheal vaccines and mucosal adjuvants.
热不稳定毒素(LT)是一种与霍乱毒素相关的蛋白质,由产肠毒素大肠杆菌菌株产生,其结构为AB5复合物。通过定点诱变构建了许多LT的无毒衍生物,这些衍生物可用于新型或改良的抗腹泻病疫苗或作为黏膜佐剂。在此,我们研究了无毒突变体LT-K7(Arg-7→Lys)、LT-D53(Val-53→Asp)、LT-K63(Ser-63→Lys)、LT-K97(Val-97→Lys)、LT-K104(Tyr-104→Lys)、LT-K114(Ser-114→Lys)和LT-K7/K97(Arg-7→Lys和Val-97→Lys)的生化特性。我们发现A亚基中的突变可能对形成AB5结构的能力以及纯化蛋白的稳定性和对胰蛋白酶的敏感性产生深远影响。不稳定的突变体在4℃长期储存期间,溶液中组装蛋白的量减少,同时可溶性单体B亚基平行出现。这一发现表明,与之相关的A亚基会影响B五聚体的稳定性。在所测试的七个无毒突变体中,发现LT-K63在AB5产生方面效率高,储存期间极其稳定,抗蛋白水解攻击,且免疫原性很强。总之,LT-K63是开发抗腹泻疫苗和黏膜佐剂的良好候选物。